Showing results (1-10 of 416) with videos related to
Sort By:
Pageof 42
Trends in Biotechnology|August 28, 2004
Targeting p53 by PTD-mediated transductionWenge Wang, Wafik S El-DeiryChemistry & Biology|April 29, 2004
Targeting FOXO kills two birds with one stoneWenge Wang, Wafik S El-DeiryCancer Biology & Therapy|May 17, 2003
Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft modelWenge Wang, Wafik S El-DeiryCurrent Opinion in Oncology|November 29, 2007
Restoration of p53 to limit tumor growthWenge Wang, Wafik S El-DeiryBiochemical Pharmacology|May 11, 2010
Current strategies to target p53 in cancerFang Chen, Wenge Wang, Wafik S El-DeiryCancer Biology & Therapy|December 25, 2008
Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73Chao Lu, Wenge Wang, Wafik S El-DeiryCancer Biology & Therapy|September 26, 2003
Restoring p53-dependent tumor suppressionWenge Wang, Farzan Rastinejad, Wafik S El-DeiryProceedings of the National Academy of Sciences of the United States of America|July 13, 2006
Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenograftsWenge Wang, Seok-Hyun Kim, Wafik S El-DeiryMolecular and Cellular Biology|March 4, 2003
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 bindingWenge Wang, Rishu Takimoto, Farzan Rastinejad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Structural and functional basis for therapeutic modulation of p53 signalingEmily A Bassett, Wenge Wang, Farzan Rastinejad, et al.Pageof 42